Royal Dutch Shell is stepping up investment in research into “second generation” biofuels, putting more money into its joint venture with Iogen, a Canadian biotech company, in spite of having made only slow progress so far.

Shell is raising its holding in the Iogen Energy joint venture to 50 per cent from 26.3 per cent and is making what it called a “significant” additional investment in the venture’s development programme.